Meet the editor

Professor Farid Badria, PhD, MSc, is the recipient of several awards including The World Academy of Sciences (TWAS) prize for Public Understanding of Science; World Intellectual Property Organization (WIPO) Gold Medal for Best Inventor; State Recognition Outstanding Award in Medicine (Egyptian Academy of Science); Outstanding Arab Scholar, Kuwait; and Khawrazmi International Award, Iran. He is also a scholar of

the Arab Development Fund, Kuwait; International Cell Research Organization (ICRO)-United Nations Educational, Scientific and Cultural Organization (UNE-SCO) International, Chile; and UNESCO Biotechnology France. Dr. Badria has 20 patents, 250 publications, more than a dozen books, several marketed pharmaceutical products, and many plenary lectures and workshops to his credit. He continues to lead research projects on developing new therapies for liver disesase, skin disorders, and cancer.

Contents

**Section 1**

**Section 2**

Omics Approach

*and Bikash Medhi*

and Challenges *by Xiao-Yuan Mao*

*and Younes Smani*

**Preface XI**

Impacts on Drug Discovery **1**

**Chapter 1 3**

**Chapter 2 23**

New Therapeutic Applications of Old Drugs **45**

**Chapter 3 47**

**Chapter 4 63**

**Chapter 5 79**

**Chapter 6 97**

Drug Repurposing: Principles Risk-Benefits and Economic

*by Mithun Rudrapal, Shubham J. Khairnar and Anil G. Jadhav*

Risk-Benefit Events Associated with the Use of Aspirin for

Drug Repurposing in Dermatology: Molecular Biology and

Drug Repurposing in Neurological Diseases: Opportunities

Drugs Repurposing for Multi-Drug Resistant Bacterial Infections *by Andrea Vila Domínguez, Manuel Enrique Jiménez Mejías* 

Drug Repurposing and Orphan Disease Therapeutics *by Neha Dhir, Ashish Jain, Dhruv Mahendru, Ajay Prakash* 

Primary Prevention of Cardiovascular Disorders *by Deepak Kumar Dash, Vishal Jain, Anil Kumar Sahu,* 

*Rajnikant Panik and Vaibhav Tripathi*

*by Farid A. Badria and Abdullah A. Elgazar*

Drug Repurposing (DR): An Emerging Approach in Drug Discovery
